Cargando…
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
Chloroquine (CQ) and its analog hydroxychloroquine (HCQ) were recently included in several clinical trials as potential prophylactic and therapeutic options for SARS-COV-2 infection/covid-19. However, drug effectiveness in preventing, treating, or slowing the progression of the disease is still unkn...
Autores principales: | Biguetti, Claudia, Marrelli, Mauro Toledo, Brotto, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Saúde Pública da Universidade de São Paulo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319500/ https://www.ncbi.nlm.nih.gov/pubmed/32638884 http://dx.doi.org/10.11606/s1518-8787.2020054002631 |
Ejemplares similares
-
The toxic effects of chloroquine and hydroxychloroquine on skeletal muscle: a systematic review and meta-analysis
por: Biguetti, Claudia Cristina, et al.
Publicado: (2021) -
Primum non nocere
por: Üreyen, Çağın Mustafa, et al.
Publicado: (2015) -
Primum non nocere
Publicado: (2020) -
Primum non nocere
Publicado: (2020) -
Primum Non Nocere
por: Sihoe, Alan D.L., et al.
Publicado: (2004)